Chandan Cancer Institute Profile
Key Indicators
- Authorised Capital ₹ 15.00 Cr
as on 08-01-2025
- Paid Up Capital ₹ 1.00 M
as on 08-01-2025
- Company Age 7 Months 20 Days
- Open Charges ₹ 15.00 Cr
as on 08-01-2025
About Chandan Cancer Institute
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 15.00 Cr and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹15.00 Cr.
Amar Singh, Asmita Singh, and Vinay Lamba serve as directors at the Company.
- CIN/LLPIN
U86100UP2024PLC204255
- Company No.
204255
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 Jun 2024
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chandan Cancer Institute?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Asmita Singh | Director | 07-Jun-2024 | Current |
Amar Singh | Director | 07-Jun-2024 | Current |
Vinay Lamba | Director | 07-Jun-2024 | Current |
Financial Performance of Chandan Cancer Institute.
Enhance accessibility to Chandan Cancer Institute's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Chandan Cancer Institute?
Unlock access to Chandan Cancer Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Chandan Pharmacy LimitedActive 7 years 5 months
Amar Singh, Asmita Singh and 1 more are mutual person
- Chandan Hospital LimitedActive 29 years 4 months
Amar Singh, Asmita Singh and 1 more are mutual person
- Amaranita Holdings (India) Private LimitedActive 16 years 8 months
Amar Singh and Asmita Singh are mutual person
- Chandan Healthcare LimitedActive 21 years 4 months
Amar Singh, Asmita Singh and 1 more are mutual person
- Chandan Diagnostic LimitedActive 27 years 1 month
Amar Singh, Asmita Singh and 1 more are mutual person
- Indra Diagnostic Centre And Blood Bank LimitedActive 32 years 11 months
Asmita Singh is a mutual person
Charges (Loans)
₹15.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 15.00 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Nov 2024 | Hdfc Bank Limited | ₹15.00 Cr | Open |
How Many Employees Work at Chandan Cancer Institute?
Unlock and access historical data on people associated with Chandan Cancer Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chandan Cancer Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chandan Cancer Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.